SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-019552
Filing Date
2020-07-17
Accepted
2020-07-17 17:54:54
Documents
1
Period of Report
2020-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3459
  Complete submission text file 0000899243-20-019552.txt   4758
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 167 EXECUTIVE DRIVE MANHASSET HILLS NY 11040
Business Address
Gitman Paul (Reporting) CIK: 0001375378 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19879 | Film No.: 201034569